Clinical Trials Update: Oct. 13, 2003
Epilepsy (Pediatric) Breast Cancer Multiple Sclerosis
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A study to evaluate the effectiveness and tolerability of an investigational medication in pediatric patients with inadequately-controlled partial seizures. Volunteers 1 to 23 months old who have a diagnosis of partial seizures may be eligible. Research sites located throughout the United States.
A study of a combination of medications in patients with locally advanced and/or metastatic breast cancer. Volunteers who have experienced no improvement within six weeks of last dose of anthracycline-based chemotherapy and whose disease has been stable after administration of a minimum of four cycles of anthracycline-based chemotherapy may be eligible. Research site located in Indianapolis, Indiana.
A study to establish the safety and effectiveness of a combination of medications for multiple sclerosis. Volunteers 18 to 55 who have a documented diagnosis of relapsing-remitting multiple sclerosis and have been treated with Interferon Beta-1a injections for at least six months but less than four years may be eligible to participate. Research site located in Kansas City, Kansas.
Copyright 2003 CenterWatch. All rights reserved.